T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Stanley Black & Decker
SWK
$15.4B
| $47.6M | ﹤0.01% |
252,551
-6,930
| -3% | -$1.28M |
|
|
HI
1027
DELISTED
Hillenbrand
HI
| $47.4M | ﹤0.01% |
910,827
-65,554
| -7% | -$3.13M |
|
1028
Kroger
KR
$35.1B
| $47.4M | ﹤0.01% |
1,046,254
-43,742
| -4% | -$1.84M |
|
1029
Fortune Brands Innovations
FBIN
$5.78B
| $47.3M | ﹤0.01% |
517,147
-13,206
| -2% | -$1.14M |
|
1030
Herc Holdings
HRI
$5.64B
| $47.2M | ﹤0.01% |
301,772
+71,522
| +31% | +$12.6M |
|
1031
NCR Voyix
VYX
$1.17B
| $47M | ﹤0.01% |
1,907,046
-2,210
| -0.1% | -$56.1K |
|
1032
Nu Holdings
NU
$67.3B
| $47M | ﹤0.01% |
+5,008,047
| New | +$49.2M |
|
1033
Church & Dwight Co
CHD
$24B
| $46.7M | ﹤0.01% |
455,555
-39,100
| -8% | -$3.55M |
|
1034
GitLab
GTLB
$7.32B
| $46.3M | ﹤0.01% |
+539,793
| New | +$55.2M |
|
1035
Equity Bancshares
EQBK
$1.07B
| $46.3M | ﹤0.01% |
1,365,603
-45,983
| -3% | -$1.55M |
|
|
ENV
1036
DELISTED
ENVESTNET, INC.
ENV
| $46.3M | ﹤0.01% |
583,453
-17,240
| -3% | -$1.4M |
|
|
CWAN
1037
DELISTED
Clearwater Analytics
CWAN
| $46.2M | ﹤0.01% |
2,012,244
+12,244
| +0.6% | +$277K |
|
1038
Metropolitan Bank Holding Corp
MCB
$1.17B
| $46M | ﹤0.01% |
431,576
+113,424
| +36% | +$10.8M |
|
1039
Kinder Morgan
KMI
$71.4B
| $46M | ﹤0.01% |
2,897,594
-121,018
| -4% | -$2.01M |
|
1040
Valero Energy
VLO
$98.7B
| $45.8M | ﹤0.01% |
609,843
-27,655
| -4% | -$2.06M |
|
1041
Extra Space Storage
EXR
$31.6B
| $45.8M | ﹤0.01% |
201,987
-7,435
| -4% | -$1.47M |
|
|
RPTX
1042
DELISTED
Repare Therapeutics
RPTX
| $45.7M | ﹤0.01% |
2,166,822
+250,849
| +13% | +$5.91M |
|
1043
Travel + Leisure Co
TNL
$4.58B
| $45.5M | ﹤0.01% |
824,096
-14,435
| -2% | -$772K |
|
1044
Sun Communities
SUI
$14.6B
| $45.4M | ﹤0.01% |
216,302
+5,019
| +2% | +$989K |
|
1045
Labcorp
LH
$26.2B
| $45.2M | ﹤0.01% |
167,455
-9,546
| -5% | -$2.36M |
|
1046
Hawkins
HWKN
$2.67B
| $45.2M | ﹤0.01% |
1,145,645
-308
| -0% | -$11.4K |
|
1047
Advanced Energy
AEIS
$13.2B
| $45M | ﹤0.01% |
494,590
+2,731
| +0.6% | +$243K |
|
1048
Hexcel
HXL
$7.74B
| $44.8M | ﹤0.01% |
865,540
+43,675
| +5% | +$2.47M |
|
1049
Consolidated Edison
ED
$40.1B
| $44.8M | ﹤0.01% |
525,456
-1,598,884
| -75% | -$126M |
|
|
DICE
1050
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $44.4M | ﹤0.01% |
1,752,791
+250,542
| +17% | +$7.34M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.